Early Embryonic Lethality Due to Targeted Inactivation of DNA Ligase III

Abstract
Whether or not FLT3 mutations are present and expressed within a leukemic hematopoietic stem cell has engendered some controversy. New evidence has now been presented on this issue that could change the way we manage the disease in the future.